An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Byfavo

Chemical Nameremimazolam
Dosage FormInjection (iIntravenous; 20 mg)
Drug ClassBenzodiazepines
SystemOther
CompanyAcacia Pharma, Inc.
Approval Year2020

Indication

  • For the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.
Last updated on 12/7/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Byfavo (remimazolam) Prescribing Information.2020Acacia Pharma, Inc. Indianapolis, IN
Document TitleYearSource
Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy.2018Chest Journal
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.2018Gastrointestinal Endoscopy